ALSO NOTED: Sanofi plans $100 million R&D facility; Vaccines safety group seeks public input; and much more...

Vaccine Research Sanofi Pasteur is blueprinting plans for a $100 million R&D facility to develop new vaccines in Toronto.

Tiny Antigenics gears up to market cancer vaccine

After spending 12 years and $425 millions of dollars in a so far unsuccessful quest to win FDA approval of Oncophage, tiny

Mumps outbreak spurs calls for a new vaccine

Health experts say that an outbreak of mumps two years ago among college students occurred even though most of them had received a recommended vaccine. And a number of physicians have concluded that

Crucell reports early-stage success with TB vaccine

Shares of Crucell jumped after the developer announced that an early-stage trial of an experimental tuberculosis vaccine demonstrated a promising immune response in volunteers. The Dutch biotech is

Brazilian Dengue outbreak highlights vaccine need

An outbreak of dengue fever in and around Rio de Janeiro has afflicted more than 75,000 people since the beginning of the year, with 12 people dying in just the past week. No vaccine is available

SPOTLIGHT: Vaccine a success for human-to-human H5N1 case

A confirmed case of bird flu in China has confirmed that the threat of human-to-human contagion is still largely limited to the blood relatives of those infected. In an important case for vaccine

ALSO NOTED: GSK gains Rotarix approval; Bavarian Nordic touts smallpox data; and much more...

Vaccine Market GlaxoSmithKline has received FDA approval for Rotarix, a vaccine to stop the leading cause of diarrhea. The approval opens the way for a direct competitor to Merck's RotaReq. Rotarix

VaxDesign offers an alternative to animal studies

Time magazine profiles the work of VaxDesign, a five-year-old biotech company that has developed simulated human immune systems, mixing blood cells and faux tissue into a special construct that can

VaxGen faces possible liquidation after merger flops

The spectacularly unsuccessful VaxGen has called off an effort to

Ebola vaccines readied for first human trials

Researchers are pushing ahead with the first human trials of an ebola vaccine. Typical vaccines spark an antibody response against a threat. But with the lethal ebola, a successful vaccine has to

Cell Genesys pact highlights cancer vaccine value

Cell Genesys' $320 million partnership deal with Takeda for its

SPOTLIGHT: Novavax teams with GE on plants

Novavax plans to duplicate its Rockville, MD vaccine-making plant in a series of small plants scattered in developing nations, creating a ring of facilities that can produce vaccines to fight a bird

ALSO NOTED: Sinovac to produce H5N1 vaccine; CG Therapeutics develops new antibodies for tumor vaccine;and much more...

Vaccine Markets Drug regulators in China have OK'd Sinovac's commercial production of a new H5N1 vaccine for humans following two years of trials.

Feds steering funds back to basic AIDS vax research

After trying and failing repeatedly to develop an AIDS vaccine, federal officials say they're going back to the drawing board to come up with some new ideas.

PharmAthene bids for big anthrax vaccine contract

PharmAthene is making a bid to develop a next-gen anthrax vaccine that can qualify for a $400 million government contract. The small Maryland developer is paying up to $40 million for a pair of

Individual investors buy into vaccination bond issue

Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs

Iomai gets boost in bird flu vaccine adjuvant study

In a Phase I/II trial, three out of every four people in a study of 500 people using an adjuvant patch developed by Iomai achieved a protective immune response after a single dose. That compares to

SPOTLIGHT: Autism link researcher faces charges

Dr. Andrew Wakefield and two colleagues will begin their defense today against charges they violated ethics guidelines in the U.K. while developing a 1998 paper that linked autism to vaccines. That

ALSO NOTED: Program eliminates polio in Somalia; New insight into malaria vaccine; and much more...

Vaccine Market A group of 10,000 volunteers and health workers has eliminated polio in Somalia through an ambitious vaccination program. And workers say the experience could help officials eradicate

Vietnamese launch human trial of bird flu vaccine

A Vietnamese company is beginning a human trial of a new bird flu vaccine. Vabiotech, a subsidiary of Vietnam's National Institute of Hygiene and Epidemiology, plans eight months of testing in a